InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

- Current share price for REG : $6.120

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,850 Ceasing to be a substantial holder from MQG 6 Apr 2022 10:47AM $2.060 $6.120 risen by 197.09%
$1,850 Becoming a substantial holder from MQG 31 Mar 2022 6:30PM $2.160 $6.120 risen by 183.33%
$1,850 Regis Healthcare Results Announcement 1H FY22 23 Feb 2022 8:27AM $1.930 $6.120 risen by 217.10%
$1,850 Dividend/Distribution - REG 23 Feb 2022 8:27AM $1.930 $6.120 risen by 217.10%
$1,850 Regis Healthcare Investor Presentation 1H FY22 Results 23 Feb 2022 8:25AM $1.930 $6.120 risen by 217.10%
$1,850 Regis Healthcare 4D And Financial Report 1H FY22 23 Feb 2022 8:23AM $1.930 $6.120 risen by 217.10%
$1,850 Initial Director's Interest Notice 19 Jan 2022 8:46AM $1.820 $6.120 risen by 236.26%
$1,850 Appointment of Non-executive Director and Operations Update 17 Jan 2022 9:49AM $1.820 $6.120 risen by 236.26%
$1,850 Non-Cash Impact of Removal of Aged Care Approval Rounds 13 Dec 2021 9:47AM $1.720 $6.120 risen by 255.81%
$1,850 Notification regarding unquoted securities - REG 29 Nov 2021 9:04AM $1.790 $6.120 risen by 241.90%
$1,850 Notification regarding unquoted securities - REG 24 Nov 2021 3:33PM $1.860 $6.120 risen by 229.03%
$1,850 Change Of Director's Interest Notice 24 Nov 2021 3:27PM $1.865 $6.120 risen by 228.15%
$1,850 Final Director's Interest Notice 28 Oct 2021 9:44AM $1.960 $6.120 risen by 212.24%
$1,850 Final Director's Interest Notice 28 Oct 2021 9:44AM $1.960 $6.120 risen by 212.24%
$1,850 Appointment of Company Secretary 27 Oct 2021 10:07AM $2.000 $6.120 risen by 206%
$1,850 Regis Healthcare - Results Of Annual General Meeting 26 Oct 2021 1:19PM $2.015 $6.120 risen by 203.72%
$1,850 Regis Healthcare - Chairman And MD Addresses To AGM 26 Oct 2021 9:41AM $2.020 $6.120 risen by 202.97%
$1,850 Application for quotation of securities - REG 28 Sep 2021 11:14AM $2.070 $6.120 risen by 195.65%
$1,850 Annual Report To Shareholders 23 Sep 2021 12:23PM $2.120 $6.120 risen by 188.68%
$1,850 Notice of Annual General Meeting/Proxy Form 23 Sep 2021 12:14PM $2.120 $6.120 risen by 188.68%
$1,850 Appendix 4G And Corporate Governance Statement 23 Sep 2021 12:12PM $2.120 $6.120 risen by 188.68%
$1,850 Regis Healthcare Investor Presentation FY2021 Results 31 Aug 2021 8:14AM $1.970 $6.120 risen by 210.66%
$1,850 Regis Healthcare Results Announcement FY2021 31 Aug 2021 8:13AM $1.970 $6.120 risen by 210.66%
$1,850 Dividend/Distribution - REG 31 Aug 2021 8:12AM $1.970 $6.120 risen by 210.66%
$1,850 Regis Healthcare Appendix 4E and Financial Report FY2021 31 Aug 2021 8:12AM $1.970 $6.120 risen by 210.66%

176 - 200 of 389 results

Page 8 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.